Compare GO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GO | AMPH |
|---|---|---|
| Founded | 1946 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2019 | 2014 |
| Metric | GO | AMPH |
|---|---|---|
| Price | $11.28 | $27.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $15.70 | ★ $35.17 |
| AVG Volume (30 Days) | ★ 3.1M | 455.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.27 |
| Revenue | ★ $4,571,346,000.00 | $723,305,000.00 |
| Revenue This Year | $11.29 | $0.74 |
| Revenue Next Year | $5.65 | $5.63 |
| P/E Ratio | ★ N/A | $12.21 |
| Revenue Growth | ★ 7.22 | N/A |
| 52 Week Low | $10.21 | $20.39 |
| 52 Week High | $20.88 | $46.11 |
| Indicator | GO | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 58.94 |
| Support Level | $10.21 | $24.92 |
| Resistance Level | $11.13 | $27.83 |
| Average True Range (ATR) | 0.41 | 1.02 |
| MACD | 0.15 | 0.18 |
| Stochastic Oscillator | 68.91 | 58.33 |
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.